GBEMISOLA ADEBAYO: Open Payments
NPI 1588244255 · LA PLATA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$284 in 13 payments from 8 companies in 2025. Trend: 2023 $103 · 2024 $111 · 2025 $284
Food & beverage: $284
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $73 |
| Corium, LLC | 2 | $50 |
| Teva Pharmaceuticals USA, Inc. | 2 | $48 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| Boston Scientific Corporation | 1 | $27 |
| TMS NeuroHealth Centers Inc. | 1 | $18 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
| Alkermes, Inc. | 1 | $16 |
Products named: ABILIFY MAINTENA, Azstarys, AUSTEDO XR, TRINTELLIX, General - Pain Management, REXULTI, TMS NeuroHealth Centers Inc., FANAPT.
Industry payments across MD — which companies pay providers there.
